VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
URGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
URGNUroGen Pharma Ltd.
$37.75$1.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksURGNQuarterly Financials

UroGen Pharma Ltd. (URGN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

UroGen Pharma Ltd. (URGN) quarterly income statement — complete revenue, gross profit & net income history

URGN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue50.96M37.84M27.48M24.21M20.25M24.57M25.2M21.85M18.78M23.53M20.85M21.14M17.19M18.09M16.1M16.6M13.56M16.17M11.35M13.03M
Revenue Growth %151.6%54.03%9.04%10.83%7.84%4.4%20.87%3.35%9.24%30.06%29.54%27.31%26.75%11.86%41.81%27.41%81.22%103.04%227.97%3403.23%
Cost of Goods Sold4.14M3.29M3.28M3.55M2.33M2.47M2.45M2.23M1.73M2.29M2.37M2.44M2.27M2.26M2.02M1.85M1.52M1.59M1.24M1.43M
COGS % of Revenue8.12%8.69%11.93%14.66%11.5%10.06%9.73%10.2%9.2%9.72%11.35%11.56%13.17%12.51%12.55%11.12%11.24%9.82%10.96%10.95%
Gross Profit46.82M34.55M24.2M20.66M17.92M22.09M22.75M19.62M17.05M21.24M18.48M18.7M14.93M15.83M14.08M14.76M12.04M14.59M10.11M11.61M
Gross Margin %91.88%91.31%88.07%85.34%88.5%89.94%90.27%89.8%90.8%90.28%88.65%88.44%86.83%87.49%87.45%88.88%88.76%90.18%89.04%89.05%
Gross Profit Growth %161.21%56.37%6.39%5.33%5.11%4%23.08%4.94%14.24%34.21%31.31%26.68%23.99%8.53%39.28%27.17%82.74%99.41%220.65%3481.79%
Operating Expenses67.08M53.66M51.59M62.11M54.84M49.75M40.3M45.46M42.79M35.85M31.98M34.08M36.97M36.11M32.16M33.47M34M34.5M33.55M34.43M
OpEx % of Revenue131.64%141.83%187.72%256.51%270.75%202.53%159.88%208.06%227.85%152.37%153.39%161.21%215.05%199.6%199.81%201.6%250.63%213.31%295.54%264.18%
Selling, General & Admin51.49M39.35M37.58M43.2M34.97M028.94M30.06M27.3M24.55M21.75M22.49M24.47M21.63M19.07M20.83M21.3M21.42M00
SG&A % of Revenue101.03%104%136.75%178.4%172.64%-114.83%137.57%145.35%104.34%104.33%106.41%142.36%119.58%118.48%125.47%157.03%132.42%--
Research & Development15.6M14.31M14.01M18.91M19.87M14.89M11.36M15.4M15.49M11.3M10.23M11.58M12.5M14.48M13.09M12.64M12.7M13.08M11.92M12.12M
R&D % of Revenue30.61%37.83%50.97%78.11%98.11%60.63%45.05%70.5%82.5%48.03%49.06%54.8%72.7%80.02%81.34%76.13%93.6%80.88%105.04%93.03%
Other Operating Expenses000001000K0000000000001000K1000K
Operating Income-20.26M-19.11M-27.39M-41.45M-36.91M-27.66M-17.55M-25.84M-25.74M-14.61M-13.5M-15.38M-22.05M-20.28M-18.09M-18.71M-21.96M-19.91M-23.44M-22.82M
Operating Margin %-39.76%-50.52%-99.65%-171.17%-182.26%-112.59%-69.61%-118.27%-137.05%-62.09%-64.74%-72.77%-128.23%-112.1%-112.36%-112.71%-161.88%-123.13%-206.5%-175.13%
Operating Income Growth %45.11%30.89%-56.09%-60.41%-43.41%-89.32%-29.96%-67.98%-16.76%27.97%25.36%17.81%-0.4%-1.84%22.84%18%15.92%26.93%19.52%28.23%
EBITDA-19.61M-18.44M-26.75M-40.85M-36.42M-27.59M-17.28M-25.58M-25.39M-14.19M-13.09M-14.95M-21.61M-19.83M-17.65M-18.24M-21.5M-19.46M-23.22M-22.61M
EBITDA Margin %-38.48%-48.72%-97.33%-168.71%-179.8%-112.31%-68.56%-117.06%-135.18%-60.28%-62.75%-70.73%-125.7%-109.62%-109.66%-109.85%-158.52%-120.34%-204.59%-173.52%
EBITDA Growth %46.15%33.18%-54.79%-59.73%-43.44%-94.5%-32.05%-71.07%-17.49%28.47%25.87%18.03%-0.51%-1.89%23.99%19.34%17.06%26.93%19.94%27.81%
D&A (Non-Cash Add-back)652K679K639K596K497K68K266K263K351K424K415K431K435K450K435K476K456K451K217K210K
EBIT-20.26M-22.87M-26.41M-49.41M-39.38M-26.56M-14.95M-29.9M-24.13M-7.85M-12.59M-20.32M-26.64M-24.96M-22.43M-18.59M-27.79M-19.89M-23.44M-22.82M
Net Interest Income-7.76M-12.1M-6.82M-7.1M-1.86M-1.08M36K-1.74M-649K-2.86M-2.98M-3.33M-2.91M-7.83M-2.25M-2.11M-280K-7.4M57K33K
Interest Income931K908K1.18M1.68M2.2M2.81M2.76M1.72M1.8M726K835K435K645K469K441K128K2K20K57K33K
Interest Expense8.69M13.01M7.99M8.78M4.07M3.89M2.72M3.46M2.45M3.59M3.81M3.76M3.55M8.3M2.69M2.24M282K7.42M00
Other Income/Expense-8.08M-7.52M-7.01M-7.48M-6.54M-7.21M-6.04M-7.53M-6.49M-7.55M-8.39M-8.7M-8.15M-7.9M-7.04M-7.94M-6.11M-7.4M-6.77M-3.09M
Pretax Income-28.35M-26.64M-34.4M-48.92M-43.45M-34.86M-23.58M-33.37M-32.23M-22.16M-21.89M-24.08M-30.19M-28.18M-25.12M-26.66M-28.07M-27.32M-30.21M-25.91M
Pretax Margin %-55.63%-70.4%-125.18%-202.04%-214.53%-141.92%-93.56%-152.71%-171.62%-94.19%-104.97%-113.92%-175.62%-155.76%-156.07%-160.56%-206.92%-168.88%-266.15%-198.82%
Income Tax-4.77M-275K-1.05M1.01M392K2.65M91K38K54K3.85M-9K54K21K689K709K32K325K1.14M0312K
Effective Tax Rate %16.83%1.03%3.06%-2.07%-0.9%-7.6%-0.39%-0.11%-0.17%-17.39%0.04%-0.22%-0.07%-2.44%-2.82%-0.12%-1.16%-4.16%0%-1.2%
Net Income-23.57M-26.36M-33.35M-49.94M-43.84M-37.51M-23.67M-33.4M-32.29M-26.02M-21.88M-24.14M-30.21M-28.87M-25.83M-26.69M-28.39M-28.45M-30.21M-26.22M
Net Margin %-46.26%-69.68%-121.34%-206.24%-216.47%-152.71%-93.93%-152.89%-171.91%-110.57%-104.93%-114.18%-175.74%-159.57%-160.47%-160.75%-209.32%-175.91%-266.15%-201.21%
Net Income Growth %46.23%29.72%-40.87%-49.51%-35.8%-44.19%-8.2%-38.39%-6.86%9.88%15.3%9.57%-6.41%-1.47%14.5%-1.79%-9.47%6.79%-4.84%16.35%
Net Income (Continuing)-23.57M-26.36M-33.35M-49.94M-43.84M-37.51M-23.67M-33.4M-32.29M-26.02M-21.88M-24.14M-30.21M-28.87M-25.83M-26.69M-28.39M-28.45M-30.21M-26.22M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.47-0.54-0.69-1.05-0.92-0.80-0.55-0.91-0.97-0.72-0.68-1.03-1.30-1.22-1.13-1.18-1.25-1.27-1.35-1.17
EPS Growth %48.91%32.5%-25.45%-15.38%5.15%-11.11%19.12%11.65%25.38%40.98%39.82%12.71%-4%3.94%16.3%-0.85%-6.84%7.97%-3.05%18.75%
EPS (Basic)-0.47-0.54-0.69-1.05-0.92-0.80-0.55-0.91-0.97-0.72-0.68-1.03-1.30-1.22-1.13-1.18-1.25-1.27-1.35-1.17
Diluted Shares Outstanding50.18M49.23M48.06M47.74M47.42M47.03M43.1M36.82M33.38M36.15M32.3M23.46M23.28M23.09M22.8M22.7M22.63M22.43M22.38M22.33M
Basic Shares Outstanding50.18M49.23M48.06M47.74M47.42M47.03M43.1M36.82M33.38M36.15M32.3M23.46M23.28M23.09M22.8M22.7M22.63M22.43M22.38M22.33M
Dividend Payout Ratio--------------------